Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 20405 

standing Tribal Advisory Council (TAC) 

expected to be composed of a diverse 

group of tribal leaders (elected or 

appointed by their Tribes); an elected or 

appointed leader of a state-recognized 

Tribe and/or Native Hawaiian 

organization; and advisors who are 

experts on tribal and indigenous issues. 

The TAC will advise GAO on vital and 

emerging issues affecting Tribes and 

Indigenous peoples for the purpose of 

informing GAO’s strategic goals and 

priorities with respect to the agency’s 

work evaluating federal programs 

serving Tribes and related topics. GAO 

is now accepting nominations for TAC 

appointments that will be effective in 

August 2022. Nominations should be 

sent to the email address listed below. 

Acknowledgement of submission will 

be provided within a week of 

submission. 

DATES: Nominations should be 

submitted no later than May 20, 2022, 

to ensure adequate opportunity for 

review and consideration of nominees 

prior to appointment. 

ADDRESSES: Submit nomination 

materials to TAC@gao.gov by May 20, 

2022. 

FOR FURTHER INFORMATION CONTACT: 

Paige Gilbreath at (214) 777–5724 or 

gilbreathp@gao.gov if you do not receive 

an acknowledgment or need additional 

information. For general information, 

contact GAO’s Office of Public Affairs, 

(202) 512–4800. 

SUPPLEMENTARY INFORMATION: 

Background 

The U.S. Government Accountability 

Office (GAO) is establishing a Tribal 

Advisory Council (TAC) to advise GAO 

on vital and emerging issues affecting 

Tribes and Indigenous peoples and 

provide input into GAO’s strategic goals 

and priorities with respect to the 

agency’s related work. Among other 

things, this may include informing GAO 

of emerging topics of interest or 

concern, helping identify relevant 

stakeholders to ensure GAO work 

includes a diverse range of tribal and 

indigenous perspectives, and providing 

advice to GAO on its processes for 

working with Tribes. 

The TAC is expected to be composed 

of up to 15 members including elected 

or appointed leaders from federally 

recognized Tribal entities, as identified 

in the Federal Register Notice 

published on January 28, 2022 (87 FR 

4636); an elected or appointed leader of 

a state recognized Tribe and/or Native 

Hawaiian organization; and technical 

advisors who may be representatives of 

national or regional tribal or Nativeserving organizations or subject-matter 

experts on topics relevant to Tribes and 

Indigenous peoples. 

Individuals selected for appointment 

to the TAC will be invited to serve terms 

of two or three years. Subject to 

availability of federal funding, the TAC 

will meet at least annually, though GAO 

may periodically ask members to 

provide information or perspectives on 

selected issues between TAC meetings. 

Appointed TAC members will receive 

per diem and reimbursement for eligible 

travel expenses incurred for attending 

TAC meetings. 

GAO will endeavor to ensure that the 

membership of the TAC is balanced in 

terms of points of view and the 

demographic, geographic, and other 

characteristics of Tribes and Native 

Hawaiian organizations represented. 

Appointments shall be made without 

discrimination on the basis of age, 

ethnicity, gender, sexual orientation, or 

cultural, religious, or socioeconomic 

status. 

Nomination Information 

Nomination materials should be 

submitted to TAC@gao.gov by May 20, 

2022. Required nomination materials 

vary based on the position the nominee 

is seeking to fill on the TAC. (1) 

Nominees who are elected or appointed 

leaders of federally or state recognized 

Tribes should obtain a tribal resolution 

certifying their nomination. This 

resolution, along with the name of the 

nominee, their Tribe, and their official 

role, should be provided to GAO in the 

nomination package. (2) Leaders of 

Native Hawaiian organizations should 

obtain a letter certifying their 

nomination from their Board of 

Directors. This letter, along with the 

name of the nominee and their official 

role, should be provided to GAO in the 

nomination package. (3) Technical 

advisors may be self-nominated or 

nominated by an individual or 

organization. Nomination materials 

should include the name of the 

nominee, the organization they 

represent (if applicable), qualifications, 

and/or a brief description of the 

nominee’s interest in serving on the 

TAC. 

About GAO 

The U.S. Government Accountability 

Office (GAO) is an independent, nonpartisan agency that works for Congress. 

GAO examines how taxpayer dollars are 

spent and provides Congress and federal 

agencies with objective, non-partisan, 

fact-based information to help the 

government save money and work more 

efficiently. 

To do so, GAO conducts reviews of 

federal agencies and programs, 

including those that serve Tribes, their 

citizens, and descendants. (GAO 

generally does not audit Tribes’ 

activities.) GAO reviews span a broad 

range of topics of concern to Tribes, 

including health care, education, 

economic development, environmental 

protection, justice, and infrastructure, 

among others. GAO’s oversight of 

federal programs that serve Tribes and 

their citizens aims to help the Congress 

determine how best to meet the 

government’s longstanding 

commitments to federally recognized 

Tribes. 

Authority: 31 U.S.C. 711–712. 

Gene L. Dodaro, 

Comptroller General of the United States. 

[FR Doc. 2022–07423 Filed 4–6–22; 8:45 am] 

BILLING CODE 1610–02–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Amended Order Implementing 

Presidential Proclamation on 

Advancing the Safe Resumption of 

Global Travel During the COVID–19 

Pandemic 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of Agency Amended 

Order. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), has amended its 

Order issued October 20, 2021, to align 

with revised CDC guidance published 

on January 4, 2022, related to isolation 

and quarantine after travel. 

DATES: This Amended Order will be 

implemented at 12:01 a.m. EDT on April 

14, 2022. 

FOR FURTHER INFORMATION CONTACT: 

Candice Swartwood, Division of Global 

Migration and Quarantine, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H24–8, Atlanta, 

GA 30329; Telephone: 404–498–1600; 

Email: dgmqpolicyoffice@cdc.gov. 

SUPPLEMENTARY INFORMATION: On 

October 25, 2021, the President issued 

a Proclamation pursuant to Sections 

1182(f) and 1185(a)(1) of Title 8, and 

Section 301 of Title 3, United States 

Code (the Proclamation) titled, 

‘‘Advancing the Safe Resumption of 

Global Travel During the COVID–19 

Pandemic.’’ Pursuant to this 

Proclamation, the President has 


khammond on DSKJM1Z7X2PROD with NOTICES
20406 Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 

1For a list of vaccines approved or authorized in 

the United States to prevent COVID–19, see https:// 

www.cdc.gov/coronavirus/2019-ncov/vaccines/ 

different-vaccines.html. 

2For more information about WHO-listed 

COVID–19 vaccines, see https://www.who.int/ 

emergencies/diseases/novel-coronavirus-2019/ 

question-and-answers-hub/q-a-detail/coronavirusdisease-(covid-19)-vaccines. 

3For purposes of this Amended Order, U.S. 

lawful permanent residents and U.S. nationals will 

be treated in the same manner as U.S. citizens. For 

more details regarding who is not a Covered 

Individual under the Order, see: https://

www.cdc.gov/coronavirus/2019-ncov/travelers/ 

proof-of-vaccination.html#immigrants. 

4CDC encourages airlines and aircraft operators 

to incorporate the attestation into paperless checkin processes. An airline or aircraft operator may use 

a third party (including a third-party application) to 

collect attestations, including to provide 

translations. However, an airline or aircraft operator 

will have sole legal responsibility to provide and 

collect attestations, to ensure the accuracy of any 

translation, and to comply with all other obligations 

under agency directives implementing the 

Proclamation. An airline or aircraft operator is 

responsible for any failure of a third party to 

comply with such directives. An airline or aircraft 

operator may not shift any legal responsibility to a 

third party. 

implemented a global suspension and 

limitation on entry for noncitizens who 

are nonimmigrants seeking to enter the 

United States by air travel and who are 

not fully vaccinated against COVID–19. 

The Proclamation directs the Secretary 

of HHS, through the CDC Director, to 

implement the Proclamation as it 

applies to public health in accordance 

with appropriate public health protocols 

and consistent with CDC’s independent 

public health judgment. The 

Proclamation does not apply to crew 

members of airlines or other aircraft 

operators if they follow industry 

standard protocols for the prevention of 

COVID–19. 

In this notice, CDC announces an 

Amended Order that revises some of the 

post-arrival requirements for certain 

people eligible for an exception to the 

vaccination requirement to travel to the 

United States. The Amended Order 

reduces the number of days for such 

persons to self-quarantine after 

international travel from seven days to 

five days. The number of days for 

isolation for those who are diagnosed 

with COVID–19 or have COVID–19 

symptoms is also reduced from 10 days 

to five days. This Amended Order 

additionally clarifies language already 

on the Attestation Form that children 

under two years of age do not need to 

complete (or have a parent or guardian 

complete on their behalf) the attestation. 

A copy of the Amended Order and 

Attestation Form is below. A copy of 

these documents can be found at: 

https://www.cdc.gov/quarantine/ordersafe-travel.html. 

Centers for Disease Control and 

Prevention (CDC) 

Department of Health and Human 

Services (HHS) 

Amended Order Implementing 

Presidential Proclamation on 

Advancing the Safe Resumption of 

Global Travel During the COVID–19 

Pandemic 

Summary 

On October 25, 2021, the President 

issued a Proclamation pursuant to 

Sections 1182(f) and 1185(a)(1) of Title 

8, and Section 301 of Title 3, United 

States Code, (the Proclamation), titled, 

‘‘Advancing the Safe Resumption of 

Global Travel During the COVID–19 

Pandemic.’’ Pursuant to this 

Proclamation, the President has 

implemented a global suspension and 

limitation on entry for noncitizens who 

are nonimmigrants seeking to enter the 

United States by air travel and who are 

not fully vaccinated against COVID–19. 

The Proclamation directs the Secretary 

of Health and Human Services (HHS), 

through the Director of the Centers for 

Disease Control and Prevention (CDC), 

to implement the Proclamation as it 

applies to public health in accordance 

with appropriate public health protocols 

and consistent with CDC’s independent 

public health judgment. 

The Proclamation does not alter the 

obligation of persons, including persons 

whose entry is not covered by the 

Proclamation, to comply with the 

requirements of state, local, territorial, 

or Tribal authorities, or the applicable 

requirements of CDC Orders, including: 

• Requirement for Negative PreDeparture COVID–19 Test Result or 

Documentation of Recovery from 

COVID–19 for All Airline or Other 

Aircraft Passengers Arriving in the 

United States from any Foreign Country 

(published at 86 FR 7387, January 28, 

2021; amended and republished at 86 

FR 69256, December 7, 2021) (as may be 

further amended); 

• Requirement for Persons to Wear 

Masks While on Conveyances and at 

Transportation Hubs (published at 86 

FR 8025, February 3, 2021) (as may be 

further amended); and 

• Other CDC Orders that may be 

published relating to preventing the 

introduction, transmission, and spread 

of COVID–19 into and throughout the 

United States. 

This Amended Order further amends 

the previous Order signed by the CDC 

Director on October 30, 2021, to align 

with revised CDC guidance related to 

isolation and quarantine after travel that 

was published on January 4, 2022. The 

new guidance reduces the number of 

days recommended for a person to selfquarantine after travel from 7 days to 5 

days. The new guidance also reduces 

the number of days recommended for 

isolation for people who are diagnosed 

with COVID–19 or have COVID–19 

symptoms from 10 days to 5 days. This 

Amended Order also clarifies language 

already on the attestation form that 

children under 2 years of age do not 

need to complete (or have a parent or 

guardian complete on their behalf) the 

attestation. The Amended Order also 

revises what is required for some people 

eligible for an exception to the 

vaccination requirement and what 

public health actions, such as selfquarantine or testing, may be required 

for such eligible people after arriving in 

the United States. This Amended Order 

shall enter into effect at 12:01 a.m. EDT 

on April 14, 2022. 

Definitions 

For purposes of this Amended Order, 

the following definitions apply: 

Accepted COVID–19 Vaccine means: 

• A vaccine authorized for emergency 

use or approved by the U.S. Food and 

Drug Administration (FDA); 1 or 

• A vaccine listed for emergency use 

(EUL) by the World Health Organization 

(WHO); 2 or 

• A vaccine or combination of 

vaccines listed by CDC in the Technical 

Instructions. 

Covered Individual means any 

passenger covered by the Proclamation 

and this Amended Order: A noncitizen 3

who is a nonimmigrant seeking to enter 

the United States by air travel. This term 

does not apply to crewmembers of 

airlines or other aircraft operators if 

such crewmembers and operators 

adhere to all industry standard 

protocols for the prevention of COVID– 

19, as set forth in relevant guidance for 

crewmember health issued by the CDC 

or by the Federal Aviation 

Administration in coordination with the 

CDC. 

Covered Individual Attestation means 

the attestation in Attachment A,4 in 

written or electronic form, that must be 

completed by each Covered Individual 

as a condition of their being able to 

enter the United States under the 

Proclamation and this Amended Order. 

Excepted Covered Individual means a 

Covered Individual who is not fully 

vaccinated against COVID–19 and meets 

the criteria for an exception under the 

Proclamation and this Amended Order. 

Foreign country means anywhere that 

is not a state, territory, or possession of 

the United States. 

Foreign Country with Limited COVID– 

19 Vaccine Availability means a foreign 

country where less than 10 percent of 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 20407 

5While not a requirement of this Amended Order, 

CDC recommends that all travelers get a booster 

dose when eligible to stay up to date with their 

COVID–19 vaccines. See https://www.cdc.gov/ 

coronavirus/2019-ncov/vaccines/stay-up-todate.html. 

6The recommended interval between the first and 

second doses of FDA-approved/authorized and 

WHO–EUL listed vaccines varies by vaccine type. 

However, for purposes of interpretation of vaccine 

records, the second dose in a two dose heterologous 

series must have been received no earlier than 17 

days (21 days with a 4-day grace period) after the 

first dose. 

7Requirement for Proof of COVID–19 Vaccination 

for Air Passengers, available at https://

www.cdc.gov/coronavirus/2019-ncov/travelers/ 

proof-of-vaccination.html. 

8 Ibid. 

9Symptoms of COVID–19, available at https://

www.cdc.gov/coronavirus/2019-ncov/symptomstesting/symptoms.html. 

10Requirement for Proof of COVID–19 

Vaccination for Air Passengers, available at https:// 

www.cdc.gov/coronavirus/2019-ncov/travelers/ 

proof-of-vaccination.html. 

11 Ibid. 

12Quarantine and Isolation, available at https://

www.cdc.gov/coronavirus/2019-ncov/your-health/ 

quarantine-isolation.html. 

13Requirement for Proof of COVID–19 

Vaccination for Air Passengers, available at https:// 

www.cdc.gov/coronavirus/2019-ncov/travelers/ 

proof-of-vaccination.html. 

14Travel Guidance for Non-U.S. Citizens, NonU.S. Immigrants, available at https://www.cdc.gov/ 

coronavirus/2019-ncov/travelers/noncitizens-USair-travel.html. 

15https://covid19.who.int/. 

16https://covid.cdc.gov/covid-data-tracker/ 

#datatracker-home. 

17 Ibid. 

18https://www.who.int/news/item/26-11-2021- 

classification-of-omicron-(b.1.1.529)-sars-cov-2- 

variant-of-concern. 

the country’s total population has been 

fully vaccinated with any available 

COVID–19 vaccine. These countries are 

listed by CDC in Technical Instructions. 

Fully Vaccinated Against COVID–19 5

means it has been: 

• 2 weeks (14 days) or more since a 

person received one dose of an accepted 

single-dose-series COVID–19 vaccine; 

OR 

• 2 weeks (14 days) or more since a 

person received a second dose in a 2- 

dose series of an accepted COVID–19 

vaccine; OR 

• 2 weeks (14 days) since a person 

received the full series of an accepted 

COVID–19 vaccine (not placebo) in a 

clinical trial; OR 

• 2 weeks (14 days) since the person 

received 2 doses of any ‘‘mix-andmatch’’ combination of accepted 

COVID–19 vaccines administered at 

least 17 days apart; 6 OR 

• 2 weeks (14 days) or more since the 

person received a complete series of a 

vaccine or combination of vaccines 

listed by CDC in Technical Instructions. 

Not Fully Vaccinated Against COVID– 

19 means a person does not meet the 

definition of Fully Vaccinated Against 

COVID–19. 

Post-Arrival Viral Test means a viral 

test taken by an Excepted Covered 

Individual, obtained 3–5 days after 

arriving in the United States or other 

period as specified in the most current 

CDC guidance in effect at the time the 

Excepted Covered Individual completes 

the Covered Individual Attestation.7

Post-Arrival Vaccination means 

completion of the primary series of an 

Accepted COVID–19 Vaccine by an 

Excepted Covered Individual followed 

by a two-week period in order to 

become Fully Vaccinated Against 

COVID–19 within 60 days of arriving in 

the United States, or as soon thereafter 

as is medically appropriate, if the 

Excepted Covered Individual plans to be 

in the United States for longer than 60 

days. 

Proof of Being Fully Vaccinated 

Against COVID–19 means a paper or 

digital format of a vaccination record or 

a verifiable vaccination record, as listed 

by CDC in Technical Instructions, 

confirming that the person is Fully 

Vaccinated Against COVID–19. 

Self-isolation/Self-isolate means 

actions taken by an Excepted Covered 

Individual who tests positive on a viral 

test for COVID–19 administered on a 

specimen collected 3–5 days (or other 

period as specified in the most current 

CDC guidance in effect at the time the 

Excepted Covered Individual completes 

the Covered Individual Attestation) after 

arriving in the United States or develops 

COVID–19 symptoms.8 9 These actions 

include separating from other 

individuals and staying in a home or 

other residence for at least 5 calendar 

days (or other period as specified in the 

most current CDC guidance in effect at 

the time the Excepted Covered 

Individual completes the Covered 

Individual Attestation) after symptom 

onset or the date of first positive test if 

asymptomatic.10 The actions also 

include observing other public health 

precautions as set forth in the most 

current CDC guidance in effect at the 

time the Excepted Covered Individual 

completes the Covered Individual 

Attestation, such as properly wearing a 

well-fitting mask any time the Excepted 

Covered Individual must be around 

other people during the isolation period 

and for an additional 5 days after ending 

isolation.11 12

Self-quarantine means actions taken 

by an Excepted Covered Individual to 

separate from other individuals after 

arriving in the United States, including 

staying in a home or other residence for 

a full 5 days, or other period as 

specified in the most current CDC 

guidance in effect at the time the 

Excepted Covered Individual completes 

the Covered Individual Attestation, and 

observing public health precautions as 

set forth in the most current CDC 

guidance in effect at the time the 

Excepted Covered Individual completes 

the Covered Individual Attestation.13 14

Viral test means a viral detection test 

for current infection (i.e., a nucleic acid 

amplification test [NAAT] or a viral 

antigen test) approved, cleared, or 

authorized by the FDA for the detection 

of SARS–CoV–2. 

United States or U.S. has the same 

definition as ‘‘United States’’ in 42 CFR 

71.1(b), meaning ‘‘the 50 States, District 

of Columbia, and the territories (also 

known as possessions) of the United 

States, including American Samoa, 

Guam, the Northern Mariana Islands, 

the Commonwealth of Puerto Rico, and 

the U.S. Virgin Islands.’’ 

Background 

Since January 2020, the respiratory 

disease known as ‘‘COVID–19,’’ caused 

by a novel coronavirus (SARS–CoV–2), 

has spread globally, including cases 

reported in all 50 states within the 

United States, plus the District of 

Columbia and all U.S. territories. As of 

March 29, 2022, there have been almost 

481,756,700 million cases of COVID–19 

globally, resulting in almost 6,128,000 

deaths.15 More than 79,827,900 cases 

have been identified in the United 

States, with new cases reported daily, 

and over 975,500 deaths attributed to 

the disease.16 Additionally, throughout 

the duration of this pandemic, cases 

have tended to surge in waves, 

especially after high-volume travel 

periods or when new variants have 

emerged.17

On November 24, 2021, the Republic 

of South Africa informed the World 

Health Organization (WHO) of a new 

variant of SARS–CoV–2, the virus that 

causes COVID–19, that was detected in 

that country. On November 26, 2021, 

WHO designated the variant B.1.1.529 

as a variant of concern and named it 

Omicron.18 This decision was based on 

the evidence presented to the Technical 

Advisory Group on SARS–CoV–2 Virus 

Evolution (TAG–VE) which is a group of 

independent experts charged with 

assessing the evolution of SARS–CoV–2 

and examining if specific mutations and 

combinations of mutations may alter 

how the virus spreads and whether it 

may cause more severe illness. The 

evidence presented to the TAG–VE 

noted that Omicron has several 

mutations that may have an impact on 


khammond on DSKJM1Z7X2PROD with NOTICES
20408 Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 

19https://www.who.int/news/item/28-11-2021- 

update-on-omicron. 

20 Johnson AG, Amin AB, Ali AR, et al. COVID– 

19 Incidence and Death Rates Among Unvaccinated 

and Fully Vaccinated Adults with and Without 

Booster Doses During Periods of Delta and Omicron 

Variant Emergence—25 U.S. Jurisdictions, April 4– 

December 25, 2021. MMWR Morb Mortal Wkly Rep. 

ePub: 21 January 2022. DOI: http://dx.doi.org/ 

10.15585/mmwr.mm7104e2. 

21Thompson MG, Natarajan K, Irving SA, et al. 

Effectiveness of a Third Dose of mRNA Vaccines 

Against COVID–19–Associated Emergency 

Department and Urgent Care Encounters and 

Hospitalizations Among Adults During Periods of 

Delta and Omicron Variant Predominance—VISION 

Network, 10 States, August 2021–January 2022. 

MMWR Morb Mortal Wkly Rep. ePub: 21 January 

2022. DOI: http://dx.doi.org/10.15585/ 

mmwr.mm7104e3. 

22 Ibid. 

23Accorsi EK, Britton A, Fleming-Dutra KE, 

Smith ZR, Shang N, Derado G, et al. Association 

Between 3 Doses of mRNA COVID–19 Vaccine and 

Symptomatic Infection Caused by the SARS–CoV– 

2 Omicron and Delta Variants. JAMA 2022. https:// 

jamanetwork.com/journals/jama/fullarticle/ 

2788485. 

24https://www.cdc.gov/coronavirus/2019-ncov/ 

vaccines/stay-up-to-date.html. 

25https://www.cdc.gov/immigrantrefugeehealth/ 

panel-physicians/covid-19-technicalinstructions.html. 

26Crewmembers on official duty assigned by the 

airline or operator that involves operation of 

aircraft, or the positioning of crew not operating the 

aircraft (i.e., on ‘‘deadhead’’ status), are exempt 

from the requirements of this Amended Order 

provided their assignment is under an air carrier’s 

or operator’s occupational health and safety 

program that follows applicable industry standard 

protocols for the prevention of COVID–19 as set 

forth in the most current relevant guidance issued 

by the CDC or the Federal Aviation Administration 

in coordination with the CDC (e.g., SAFO 20009, 

COVID–19: Updated Interim Occupational Health 

and Safety Guidance for Air Carriers and Crews, 

available at https://www.faa.gov/other_visit/ 

aviation_industry/airline_operators/airline_safety/ 

safo/all_safos/media/2020/SAFO20009.pdf.). 

27CDC Technical Instructions: https://

www.cdc.gov/quarantine/order-safe-travel/ 

technical-instructions.html. 

28 Ibid. 

29Requirement for Proof of COVID–19 

Vaccination for Air Passengers, available at https:// 

www.cdc.gov/coronavirus/2019-ncov/travelers/ 

proof-of-vaccination.html. 

how easily it spreads or the severity of 

illness it causes.19

Even as COVID–19 rates fall in most 

of the United States, Omicron and subvariants are still highly prevalent in 

other parts of the world. WHO and CDC 

continue to collaborate with researchers 

around the world to better understand 

Omicron and track potential future 

variants of SARS–CoV–2. Studies 

include assessments of transmissibility, 

severity of infection (including 

symptoms), and how well people who 

are fully vaccinated and boosted are 

protected against infection, 

hospitalization, and death. While data 

indicate that current vaccines are less 

effective at preventing infection from 

Omicron as compared to other variants, 

data also suggest that hospitalization 

and death rates are lower for individuals 

infected with Omicron who are 

vaccinated compared with other 

variants.20 21 With an estimated 100 

percent increase in transmission for 

Omicron when compared to the original 

virus, vaccinations continue to play an 

important role in protecting the public 

from severe illness.22 A booster dose of 

vaccine mitigates the reduction in 

vaccine effectiveness, and CDC has 

provided guidance advising that people 

stay up to date with their COVID–19 

vaccines, including getting a booster 

dose if eligible.23 24

The United States is taking a multilayered approach to combatting COVID– 

19 by taking concurrent efforts to 

prevent and slow the continued 

introduction of cases and further spread 

of the virus within U.S. communities. 

Vaccines remain the best public health 

measure to protect people from severe 

illness or death from COVID–19, slow 

transmission, and reduce the likelihood 

of new variants emerging. 

On October 25, 2021, the President 

issued a Proclamation under 3 U.S.C. 

301 and 8 U.S.C. 1182(f), 1185(a)(1), 

titled, ‘‘Advancing the Safe Resumption 

of Global Travel During the COVID–19 

Pandemic.’’ The Proclamation revoked 

prior, country-specific presidential 

proclamations issued under these 

authorities in response to the outbreak 

of COVID–19. In their place, the 

President implemented a global 

suspension and restriction on entry for 

noncitizens who are nonimmigrants 

seeking to enter the United States by air 

travel and who are not fully vaccinated 

against COVID–19, with only limited 

exceptions. This Amended Order and 

associated Technical Instructions 

continue to implement the 

Proclamation. As further explained in 

this Amended Order, CDC continues to 

implement the Proclamation and require 

that Covered Individuals who are fully 

vaccinated show Proof of Being Fully 

Vaccinated Against COVID–19 and 

complete a Covered Individual 

Attestation attesting that they are fully 

vaccinated. Excepted Covered 

Individuals who are unable to present 

Proof of Being Fully Vaccinated Against 

COVID–19 must present a Covered 

Individual Attestation to the airline or 

aircraft operator prior to boarding the 

aircraft and attest that they have 

arranged to take specified public health 

actions after arrival in the United States. 

Persons Whose Entry Is Not Covered by 

the Proclamation or Who Are Excepted 

Covered Individuals 

The Proclamation applies only to nonU.S. citizens seeking entry as 

nonimmigrants. Individuals seeking 

admission to the United States as 

immigrants are subject to the medical 

examination and vaccination 

requirements of 8 U.S.C. 1182(a)(1)(A) 

and 42 CFR part 34. These requirements 

are further described in CDC’s COVID– 

19 Technical Instructions for Panel 

Physicians.25

The Proclamation does not apply to 

crewmembers of airlines or other 

aircraft operators if they follow industry 

standard protocols for the prevention of 

COVID–19.26 27 Accordingly, per the 

terms of the Proclamation, these 

individuals are not Covered Individuals 

and are not required to present Proof of 

Being Fully Vaccinated nor required to 

present a completed Covered Individual 

Attestation to the airline or aircraft 

operator before boarding an aircraft 

destined to the United States. 

The Proclamation permits Excepted 

Covered Individuals to enter the United 

States by air if they meet certain criteria 

as determined by the CDC. Except for 

children under the age of 2 years, 

Excepted Covered Individuals are 

required to present a Covered Individual 

Attestation to the airline or aircraft 

operator before boarding an aircraft 

destined to the United States attesting 

that they meet criteria outlined in the 

Technical Instructions for certain 

categories of exceptions.28

In the Covered Individual Attestation, 

Excepted Covered Individuals must also 

attest to arranging to take specified postarrival public health actions that, 

depending on the exception, could 

include a Post-arrival Viral Test, Selfquarantine, or Self-isolation if they test 

positive; and a Post-arrival Vaccination 

if their exception requires it and they 

are staying in the country for more than 

60 days. Information about the 

requirements for these actions is 

detailed in the definitions of this 

Amended Order, Technical Instructions, 

and in CDC guidance.29 The exception 

categories include: 

Diplomatic and Official Foreign 

Government Travel. The Proclamation 

excepts any noncitizen seeking entry 

into or transiting the United States for 

certain diplomatic or official foreign 

government activities. This includes: 

• Noncitizens traveling pursuant to 

one of the following nonimmigrant visa 

classifications: A–1, A–2, C–2, C–3 (as 

a foreign government official or 

immediate family member of an 

official), E–1 (as an employee of TECRO 

or TECO or the employee’s immediate 

family members), G–1, G–2, G–3, G–4, 

NATO–1 through NATO–4, or NATO–6 

(or seeking to enter as a nonimmigrant 

in one of those NATO classifications); or 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 20409 

30As noted in Frequently Asked Questions on 

CDC’s website (see https://www.cdc.gov/ 

coronavirus/2019-ncov/travelers/proof-ofvaccination.html), this policy has been in place 

since December 2021 and was subsequently 

included in the Covered Individual Attestation. It 

is incorporated into the substance of this Amended 

Order, consistent with the need to expedite 

diplomatic and official foreign government travel 

and comity regarding how U.S. diplomats are 

treated abroad. 

31https://www.cdc.gov/coronavirus/2019-ncov/ 

vaccines/recommendations/children-teens.html. 

32https://www.who.int/news/item/24-11-2021- 

interim-statement-on-covid-19-vaccination-forchildren-and-adolescents. 

33https://www.cdc.gov/quarantine/order-safetravel/technical-instructions.html (Table 3). 

34Objections to vaccination based on religious or 

moral convictions do not qualify under this or any 

other exception listed in the Proclamation or this 

Amended Order. 

• Any noncitizen whose travel falls 

within the scope of section 11 of the 

United Nations Headquarters Agreement 

or other travel pursuant to a United 

States legal obligation (as evidenced by 

a letter of invitation from the United 

Nations or other documentation 

showing the purpose of such travel). 

These persons must provide proof of 

their visa classification or an official 

letter, such as a letter from the U.S. 

government or foreign government. If 

they have been invited by the United 

Nations, they will need to present a 

letter of invitation from the United 

Nations or other documentation 

showing the purpose of such travel. 

They will also be required to provide 

the Covered Individual Attestation to 

the airline or aircraft operator before 

boarding an aircraft destined to the 

United States. In the attestation, they 

must attest to having arranged to receive 

a Post-arrival Viral Test after arriving in 

the United States; to Self-quarantine, 

except during periods when their 

attendance is required to carry out the 

purposes of the diplomatic or official 

foreign government travel (e.g., to attend 

official meetings or events); and Selfisolate if the result of the post-arrival 

viral test is positive or if they develop 

COVID–19 symptoms. Individuals who 

meet the Diplomatic and Official 

Foreign Government Travel exception 

will not be required to attest to 

arranging for a Post-arrival 

Vaccination.30

Children. The Proclamation excepts 

noncitizens who are nonimmigrants for 

whom, given their age, requiring 

vaccination would be inappropriate as 

determined by the CDC, taking into 

account global vaccine availability for 

individuals in that age group. In the 

United States, COVID–19 vaccinations 

are widely available for children and 

adolescents, with a vaccine approved or 

authorized for those 5 years and older.31

However, the same availability does not 

exist globally.32 Accordingly, 

considering the difficulty potentially 

posed to families traveling together 

when some members of the family can 

be vaccinated and others cannot, 

persons under the age of 18 years meet 

the age-based exception in the 

Proclamation. 

Noncitizens who are nonimmigrants 

and who are children ages 2 through 17 

and unable to present Proof of Being 

Fully Vaccinated Against COVID–19 

must present a completed Covered 

Individual Attestation to the airline or 

aircraft operator prior to embarking an 

aircraft destined to the United States. 

CDC has determined that children under 

2 years of age do not need to have an 

attestation completed because many are 

infants in arms, who are not required to 

have an airline ticket and for whom an 

attestation presents significant logistical 

burdens. Children ages 2 through 17 

will be required to attest (or have a 

parent or guardian attest on their behalf) 

to arranging to get a Post-arrival Viral 

Test and Self-isolate if the test result is 

positive or if the child develops COVID– 

19 symptoms. However, children ages 2 

through 17 will not be required to attest 

(or have a parent or guardian attest on 

their behalf) to having arranged to Selfquarantine in the United States after 

arrival. Based on the potential difficulty 

that self-quarantine may pose to 

children ages 2 through 17, especially 

when accompanied by a vaccinated 

parent or guardian who is not required 

to self-quarantine, CDC has determined 

that self-quarantine should not be 

required. As previously stated, children 

under 2 years of age are not required to 

attest (or have a parent or guardian 

attest on their behalf) to arranging to 

complete any post-arrival public health 

requirements. CDC believes that this 

approach fairly balances the interests of 

families traveling to the United States 

with protecting the public’s health. CDC 

guidance strongly recommends 

vaccination for all adolescents and 

eligible children. However, given the 

still evolving circumstances of 

vaccination for children, attestation 

regarding post-arrival vaccination will 

not be required for children ages 2 

through 17 at this time. This 

determination will be periodically 

reevaluated. 

Clinical Trials. The Proclamation 

excepts noncitizens who are 

nonimmigrants and who have 

participated or are participating in 

certain clinical trials for COVID–19 

vaccination, as determined by the CDC. 

Qualifying vaccine candidates that meet 

CDC criteria for the exception are 

specified in the Technical 

Instructions.33 Because these clinical 

trial participants may have received a 

COVID–19 vaccine or series of COVID– 

19 vaccines that do not meet the 

definition of an Accepted COVID–19 

Vaccine, these participants may not be 

able to present Proof of Being Fully 

Vaccinated Against COVID–19. 

Accordingly, noncitizens who are 

nonimmigrants and who have 

participated or are participating in 

certain COVID–19 vaccine trials and 

unable to present Proof of Being Fully 

Vaccinated Against COVID–19 must 

present a completed Covered Individual 

Attestation to the airline or aircraft 

operator prior to embarking an aircraft 

destined to the United States. 

To meet the clinical trial exception, 

Covered Individuals must provide 

official documentation of clinical trial 

participation outlined further in the 

Technical Instructions. Those who meet 

the clinical trial exception must attest 

(or have a parent or guardian attest on 

their behalf) to having arranged to 

receive a Post-arrival Viral Test, and 

Self-isolate if the test result is positive 

or if they develop COVID–19 symptoms. 

However, CDC has determined that 

these individuals should not be required 

to attest to arranging to self-quarantine 

or to be vaccinated after arriving in the 

United States. Requiring self-quarantine 

after arrival could potentially 

discourage clinical trial participation 

which would not serve the interests of 

public health and requiring vaccination 

could potentially invalidate the clinical 

trial study. 

Medical Contraindications. The 

Proclamation excepts noncitizens who 

are nonimmigrants for whom receiving 

an accepted COVID–19 vaccine is 

medically contraindicated as 

determined by CDC.34 Accordingly, 

CDC has determined that for an 

individual to meet this exception, a 

licensed physician must have 

determined that the individual has a 

medical contraindication to an accepted 

COVID–19 vaccine (e.g., a demonstrated 

anaphylactic reaction to a prior dose of 

a COVID–19 vaccine or vaccine 

component). As further described in the 

Technical Instructions, such individuals 

are not required to present Proof of 

Being Fully Vaccinated Against COVID– 

19. COVID–19 vaccinations have been 

overwhelmingly proven to be safe and 

effective at preventing severe illness, 

hospitalizations, and deaths from 

COVID–19. However, as is the case with 

any vaccine, certain medical 

complications can occur, such as a 

severe allergic reaction. CDC intends for 

this exception to be applied in strict 


khammond on DSKJM1Z7X2PROD with NOTICES
20410 Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 

35https://covid.cdc.gov/covid-data-tracker/ 

#datatracker-home. 

36https://media.defense.gov/2022/Jan/11/ 

2002920095/-1/-1/1/FORCE-HEALTHPROTECTION-GUIDANCE-SUPPLEMENT-20- 

REVISION-1-DEPARTMENT-OF-DEFENSEGUIDANCE-FOR-PERSONNEL-TRAVELINGDURING-THE-CORONAVIRUS-DISEASE-2019- 

PANDEMIC.PDF. 

37See CDC’s guidance: https://www.cdc.gov/ 

coronavirus/2019-ncov/travelers/proof-ofvaccination.html for additional information 

regarding post-arrival public health management of 

sea crew. Relevant CDC guidance pertaining to sea 

crew members serving on board cruise ships has 

been issued separately (available at https://

www.cdc.gov/quarantine/cruise/index.html). 

Additional guidance applicable to crew serving 

onboard all vessels is available at https://

www.cdc.gov/quarantine/maritime/ 

recommendations-for-ships.html. 

accordance with scientific evidence and 

has provided additional details 

concerning exceptions for medical 

contraindications in the Technical 

Instructions. Persons who believe they 

meet the criteria for this exception must 

present a signed letter from a licensed 

physician documenting a medical 

contraindication to receiving a COVID– 

19 vaccine. In the Covered Individual 

Attestation, they must attest that they 

meet the exception, and must attest to 

having arranged to obtain a Post-arrival 

Viral Test, Self-quarantine, and Selfisolate if they test positive or if they 

develop COVID–19 symptoms. 

Humanitarian and Emergency 

Exceptions. The Proclamation excepts 

any noncitizen nonimmigrant who has 

been granted an exception by the CDC 

for humanitarian or emergency reasons, 

as determined by the CDC. CDC applies 

this exception extremely narrowly, such 

as when an individual must travel to the 

United States to preserve health and 

safety (e.g., emergency medical 

evacuations) and is unable to complete 

the vaccination requirement before 

travel. Individuals and organizations 

sponsoring individuals who meet the 

exception criteria should contact the 

U.S. embassy or consulate in or nearest 

the country from which they are 

departing for the United States. The 

embassy will then transmit this 

information to CDC for consideration. 

Any noncitizen who is a nonimmigrant 

granted an exception for humanitarian 

or emergency reasons must present an 

official U.S. government letter and a 

completed Covered Individual 

Attestation to the airline or aircraft 

operator prior to embarking an aircraft 

destined to the United States. Such 

individual must attest to having 

arranged to obtain a Post-arrival Viral 

Test, Self-quarantine, and Self-isolate if 

they test positive or develop COVID–19 

symptoms. They also must attest to 

having arranged to receive a Post-arrival 

Vaccination within 60 days of arriving 

in the United States, or as soon 

thereafter as is medically appropriate as 

determined by CDC, if they intend to 

stay in the United States for more than 

60 days. 

Limited Vaccine Availability. The 

Proclamation excepts any noncitizen 

who is a nonimmigrant with a 

nonimmigrant visa (excluding a B–1 or 

B–2 visa) and who is a citizen of a 

Foreign Country with Limited COVID–19 

Vaccine Availability, which is defined 

pursuant to the Proclamation and this 

Amended Order as a foreign country 

where less than 10 percent of the 

country’s total population has been fully 

vaccinated with any available COVID– 

19 vaccine or is otherwise determined 

by the Director of the CDC to qualify as 

a country where the availability of 

COVID–19 vaccination is limited.35 The 

list of countries falling below the 10 

percent threshold is maintained by CDC 

in the Technical Instructions and 

reviewed on a regular basis. In 

developing and maintaining this list, 

CDC relies on official source data as 

reported by foreign ministries of health 

but may also rely on other sources such 

as additional information provided by 

U.S. embassies and consulates. 

Individuals entering the United States 

under this exception must show proof 

that they meet the exception through a 

passport issued by a foreign country 

with limited COVID–19 vaccine 

availability and a non-B–1 or B–2 

nonimmigrant visa as well as a 

completed Covered Individual 

Attestation to the airline or aircraft 

operator prior to embarking an aircraft 

destined to the United States. 

Additionally, these individuals must 

attest to having arranged to obtain a 

Post-arrival Viral Test, Self-quarantine, 

and Self-isolate if they test positive or 

develop COVID–19 symptoms. They 

also must attest to having arranged to 

receive a Post-arrival Vaccination 

within 60 days of arriving in the United 

States, or as soon thereafter as is 

medically appropriate as determined by 

CDC, if they intend to stay in the United 

States for more than 60 days. 

Members of the U.S. Armed Forces. 

The Proclamation and this Amended 

Order except noncitizens who are 

members of the U.S. Armed Forces and 

the spouses and children under 18 years 

of age of members of the U.S. Armed 

Forces. CDC applies this exception in a 

similar manner as in the CDC Order, 

Requirement for Proof of Negative 

COVID–19 Test or Recovery from 

COVID–19 for All Air Passengers 

Arriving in the United States. Members 

of the U.S. Armed Forces and their 

family members observe U.S. 

Department of Defense (DoD) guidance 

to prevent the transmission of COVID– 

19 as set forth in Force Protection 

Guidance (Supplement 20) Revision 1— 

Department of Defense Guidance for 

Personnel Traveling During the 

Coronavirus Disease 2019 Pandemic 36

(January 10, 2022) or subsequent 

updated DoD guidance. Accordingly, 

members of the U.S. Armed Forces and 

their family members, if traveling with 

a U.S. military identification document 

or other proof of status as a member of 

the U.S. Armed Forces or as a spouse, 

or child ages 2 through 17 of a member 

of the U.S. Armed Forces, must attest (or 

have a parent or guardian attest on their 

behalf if a child ages 2 through 17) to 

their status on the Covered Individual 

Attestation, but are not required to attest 

to having arranged to complete any 

post-arrival public health requirements. 

As previously stated, children under 2 

years of age are not required to attest or 

have a parent or guardian attest on their 

behalf, to having arranged to complete 

any post-arrival public health 

requirements. 

Sea Crew Members. The Proclamation 

excepts any noncitizen seeking entry to 

or transiting through the United States 

as a sea crew member traveling pursuant 

to a C–1 and D nonimmigrant visa if 

such sea crew member adheres to all 

industry standard protocols for the 

prevention of COVID–19, as set forth in 

relevant guidance for sea crew member 

health by the CDC.37 Any passenger 

granted an exception as a sea crew 

member must present documentation to 

the airline from their employer 

indicating that their entry to or transit 

through the United States is required for 

the purpose of operating a vessel or 

return travel after disembarking the 

vessel. Sea crew members entering the 

United States under this exception must 

present a completed Covered Individual 

Attestation to the airline or aircraft 

operator prior to embarking an aircraft 

destined to the United States. Sea crew 

members traveling on this exception 

also must attest to having arranged to 

obtain a Post-arrival Viral Test, Selfquarantine, and Self-isolate if they test 

positive or develop COVID–19 

symptoms. They also must attest to a 

Post-arrival Vaccination within 60 days 

of arriving in the United States, or as 

soon thereafter as is medically 

appropriate as determined by CDC if 

they intend to stay in the United States 

for more than 60 days. Given that sea 

crew members may need to board a ship 

soon after arrival in the United States, 

CDC has provided additional 

information about how Excepted 

Covered Individuals who are sea crew 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 20411 

38https://www.cdc.gov/coronavirus/2019-ncov/ 

travelers/proof-of-vaccination.html#faq-exceptions. 

39CDC considers 60 days an appropriate time 

frame for requiring that persons arriving in the 

United States be fully vaccinated against COVID– 

19. The mRNA COVID–19 vaccines (PfizerBioNTech and Moderna) available in the United 

States are administered 3–4 weeks apart (see 

https://www.cdc.gov/coronavirus/2019-ncov/ 

vaccines/different-vaccines.html). It takes 14 days 

after the second dose to be considered fully 

vaccinated. Therefore, it is reasonable to conclude 

that individuals should be able to complete the 

vaccination series and the 14-day period within 60 

days of arriving in the United States. 

40Quarantine and Isolation, available at https://

www.cdc.gov/coronavirus/2019-ncov/your-health/ 

quarantine-isolation.html. 

41Travel Guidance for Non-U.S. Citizens, NonU.S. Immigrants, available at https://www.cdc.gov/ 

coronavirus/2019-ncov/travelers/noncitizens-USair-travel.html. 

members can meet the requirements of 

the Amended Order and post-arrival 

requirements on CDC’s website.38

National Interest Exception. The 

Proclamation excepts any noncitizen or 

group of noncitizens whose entry would 

be in the U.S. national interest, as 

determined by the Secretary of State, the 

Secretary of Transportation, or the 

Secretary of Homeland Security or their 

designees. Any Excepted Covered 

Individual granted an exception in the 

national interest must present an official 

U.S. government letter and a completed 

Covered Individual Attestation to the 

airline or aircraft operator prior to 

embarking an aircraft destined to the 

United States. Such an individual must 

also attest to having arranged to: Obtain 

a Post-arrival Viral Test; Selfquarantine, except during periods when 

attendance is required to carry out the 

purposes of the travel for the U.S. 

national interest (e.g., to attend official 

meetings or events); and Self-isolate if 

they test positive or develop COVID–19 

symptoms. They also must attest to 

having arranged to receive a Post-arrival 

Vaccination within 60 days of arriving 

in the United States, or as soon 

thereafter as is medically appropriate, if 

they intend to stay in the United States 

for more than 60 days. 

Requirement To Provide a Covered 

Individual Attestation 

The Proclamation directs the HHS 

Secretary, acting through the CDC 

Director, to implement the Proclamation 

as it applies to public health through 

such procedures as may be established, 

and consistent with CDC’s independent 

public health judgment. In accordance 

with the President’s direction, this 

Amended Order requires that Covered 

Individuals seeking to enter the United 

States by air travel who are fully 

vaccinated may embark an aircraft 

destined for the United States only if 

they show Proof of Being Fully 

Vaccinated Against COVID–19 and 

complete a Covered Individual 

Attestation attesting that they are fully 

vaccinated. 

Additionally, Covered Individuals 

seeking to enter the United States by air 

travel and who are not Fully Vaccinated 

Against COVID–19 may embark an 

aircraft destined for the United States 

only if they qualify as Excepted Covered 

Individuals pursuant to the 

Proclamation. Under the Proclamation 

and this Amended Order, such 

individuals must agree, depending on 

their category of exception, that they 

will comply with applicable public 

health precautions established by CDC 

to protect against the public health risk 

posed by these travelers entering into 

the United States. These include: 

• Providing proof in the form of an 

attestation of pre-departure testing for 

COVID–19 or documentation of 

recovery from COVID–19, as determined 

by the CDC; 

• taking precautions during air travel 

to protect against the further 

introduction, transmission, and spread 

of COVID–19, including by complying 

with the requirement to wear a face 

mask, as determined by the CDC; 

• providing proof in the form of an 

attestation of having arranged for postarrival testing for COVID–19, as 

determined by the CDC; and 

• providing proof in the form of an 

attestation of having arranged to selfquarantine or self-isolate after arriving 

in the United States, as determined by 

the CDC. 

Some categories of Excepted Covered 

Individuals (subject to certain 

exceptions) must also attest to having 

arranged to become fully vaccinated 

against COVID–19 within 60 days 39 of 

arriving in the United States if the 

individual intends to stay in the United 

States for more than 60 days, or as soon 

thereafter as is medically appropriate as 

determined by the CDC, and must 

provide proof in the form of an 

attestation of having arranged to become 

fully vaccinated against COVID–19 after 

arriving in the United States. 

The Covered Individual Attestation 

must be completed, in written or 

electronic form, by the Covered 

Individual and is subject to 18 U.S.C. 

1001. As further explained in the 

attached Attestation form (Attachment 

A), persons who knowingly submit false 

information may be subject to fines, 

imprisonment, and other penalties. 

Airlines or other aircraft operators, as 

directed by the Transportation Security 

Administration (TSA), including 

through the Security Directive issued, 

and consistent with this Amended 

Order, are required to retain a copy of 

the Covered Individual Attestation for 2 

years; however, individuals are not 

required to retain a copy of the 

attestation in their possession upon 

arriving in the United States. 

Future CDC Orders implementing the 

Proclamation may require other public 

health measures consistent with the 

Proclamation to protect against the 

further introduction, transmission, and 

spread of COVID–19 into the United 

States by Covered Individuals. 

Statement of Good Cause Under the 

Administrative Procedure Act 

This Amended Order is not a 

legislative rule within the meaning of 

the Administrative Procedure Act 

(APA), but rather an Order 

implementing the Proclamation, which 

itself is not subject to the APA. Because 

this Amended Order qualifies as a 

legislative rule under the APA, notice 

and comment and a delay in the 

effective date are not required because 

there is good cause to dispense with 

prior public notice and comment and 

for a delay in the effective date. See 5 

U.S.C. 553(b)(B), (d)(3). Considering the 

rapid and unpredictable developments 

in the public health emergency caused 

by COVID–19, it would be impracticable 

and contrary to the public’s health, and 

by extension the public’s interest, to 

delay the issuance and effective date of 

this Amended Order implementing the 

Proclamation. In light of the rapid 

spread of Omicron and its impact on 

travel, any delay in issuing these 

amendments would adversely affect 

travelers and the air travel industry by 

depriving these persons and entities of 

the ability to rely on the most up-to-date 

findings and scientific determinations 

relating to the ongoing COVID–19 

pandemic. In addition, the APA does 

not require a delay in the effective date 

because this Amended Order relieves 

certain restrictions. See 5 U.S.C. 

553(d)(1). 

This Amended Order is being issued 

to align with revised CDC guidance 

related to isolation and quarantine after 

travel that was published on January 4, 

2022 and make other changes based on 

CDC’s public health expertise. Revised 

CDC guidance reduces the number of 

days recommended for a person to selfquarantine after travel from 7 to 5 

days.40 41 Additionally, the new 

guidance reduces the number of days 

recommended for isolation for people 

who are diagnosed with COVID–19 or 

have COVID–19 symptoms from 10 days 

to 5 days. Further delay to these updates 


khammond on DSKJM1Z7X2PROD with NOTICES
20412 Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 

42Requirement for Proof of COVID–19 

Vaccination for Air Passengers, available at https:// 

www.cdc.gov/coronavirus/2019-ncov/travelers/ 

proof-of-vaccination.html. 

43Parents or guardians of children under 2 years 

of age do not need to attest on behalf of these 

children, but they must present proof of the child’s 

age to the airline or aircraft operator before 

boarding. 

44CDC has provided a combined passenger 

disclosure and attestation that fulfills the 

requirements of CDC Orders: Requirement for Proof 

of Negative COVID–19 Test Result or Recovery from 

COVID–19 for All Airline Passengers Arriving into 

the United States and Order Implementing 

Presidential Proclamation on Advancing the Safe 

Resumption of Global Travel During the COVID–19 

Pandemic. 

may result in travelers quarantining or 

isolating longer than needed after travel. 

This Amended Order also allows for 

these time periods to be adjusted if 

further updates are made to CDC’s 

guidance. Updates will be reflected in 

the attestation and on CDC’s website.42

This Amended Order also provides 

that children under 2 years of age do not 

need to complete (or have a parent or 

guardian complete on their behalf) an 

attestation, revises what is required for 

Excepted Covered Individuals to meet 

the criteria for an exception, and 

provides more clarity on what public 

health actions (e.g., Self-quarantine, 

Post-arrival Viral Test) may be required 

after arriving in the United States. It is 

imperative that these amendments be 

issued without further delay so that 

affected individuals have the necessary 

clarity when arranging their travel and 

post-travel plans in accordance with the 

requirements of this Amended Order. 

Overall, these updates reduce the 

burden to the air passenger, such as by 

reducing the time period they would be 

required to attest to arranging after 

arrival in the United States and being 

more explicit about which activities are 

not required for certain exceptions. 

This Amended Order is an 

economically significant regulatory 

action under Executive Order 12866 and 

has therefore been reviewed by the 

Office of Information and Regulatory 

Affairs of the Office of Management and 

Budget. Similarly, the Office of 

Information and Regulatory Affairs has 

determined that if this Amended Order 

were a rule, it would be a major rule 

under Subtitle E of the Small Business 

Regulatory Enforcement Fairness Act of 

1996 (the Congressional Review Act), 5 

U.S.C. 804(2), but there would not be a 

delay in its effective date as the agency 

has determined that there would be 

good cause to make the requirements 

herein effective immediately under the 

APA, 5 U.S.C. 808(2). 

If any provision of this Amended 

Order continuing to implement the 

Proclamation, or the application of any 

provision to any carriers, persons, or 

circumstances, shall be held invalid, the 

remainder of the provisions, or the 

application of such provisions to any 

carriers, persons, or circumstances other 

than those to which it is held invalid, 

shall remain valid and in effect. 

Pursuant to 5 U.S.C. 553(b)(B), and for 

the reasons stated above, I hereby 

conclude that notice-and-comment 

rulemaking would defeat the purpose of 

this Amended Order implementing the 

Proclamation and endanger the public 

health, and is, therefore, impracticable 

and contrary to the public interest. For 

the same reasons, I have determined, 

consistent with 5 U.S.C. 553(d)(3), that 

there is good cause to make this 

Amended Order implementing the 

Proclamation effective without a 30-day 

delay in effective date. In addition, 

consistent with 5 U.S.C. 553(d)(1), this 

Amended Order implementing the 

Proclamation does not require a 30-day 

delay in effective date because it 

relieves certain restrictions. 

Action 

Accordingly, for the reasons set forth 

in the Proclamation and in this 

Amended Order: 

1. Directions to Airlines and Other 

Aircraft Operators 

As directed by TSA, including 

through its Security Directive or 

Emergency Amendment issued after 

consultation with CDC, and consistent 

with this Amended Order, any airline or 

other aircraft operator transporting by 

air into the United States individuals 

who are Covered Individuals from any 

foreign country, as determined and 

confirmed by the airline or other aircraft 

operator, is required to: 

A. Confirm that every Covered 

Individual, unless excepted, prior to 

boarding the aircraft, has presented 

paper or digital documentation of Proof 

of Being Fully Vaccinated Against 

COVID–19 that includes personal 

identifiers (e.g., name and date of birth) 

that match the personal identifiers on 

the passenger’s passport or other travel 

documents, and provides a Covered 

Individual Attestation. 

B. Confirm that every Covered 

Individual who has not presented Proof 

of Being Fully Vaccinated Against 

COVID–19 prior to boarding the aircraft 

has presented documentation proving 

that they are an Excepted Covered 

Individual under the Proclamation and 

this Amended Order as further 

explained by CDC in the Technical 

Instructions. 

C. Confirm that every Excepted 

Covered Individual 43 who has not 

presented Proof of Being Fully 

Vaccinated Against COVID–19 prior to 

boarding the aircraft provides a Covered 

Individual Attestation, and as further 

explained in the Technical Instructions, 

attests to the following (as applicable): 

a. Being excepted from the 

requirement to present Proof of Being 

Fully Vaccinated Against COVID–19 for 

one of the reasons set forth in the 

Proclamation and this Amended Order; 

b. having arranged to be tested with 

a COVID–19 viral test 3–5 days after 

arriving in the United States, or other 

period as specified in the most current 

CDC guidance in effect at the time the 

Excepted Covered Individual completes 

the Covered Individual Attestation, 

unless the Excepted Covered Individual 

has documentation of having recovered 

from COVID–19 in the past 90 days, or 

other period as specified in the most 

current CDC guidance in effect at the 

time the Excepted Covered Individual 

completes the Covered Individual 

Attestation; 

c. having arranged to self-quarantine, 

even if the test result to the post-arrival 

viral test is negative, unless the 

Excepted Covered Individual has 

documentation of having recovered 

from COVID–19 in the past 90 days or 

other period as specified in the most 

current CDC guidance in effect at the 

time the Excepted Covered Individual 

completes the Covered Individual 

Attestation; and 

d. having arranged to self-isolate if the 

result of the post-arrival viral test is 

positive or if they develop COVID–19 

symptoms. 

D. Confirm that every Excepted 

Covered Individual who does not 

present Proof of Being Fully Vaccinated 

Against COVID–19, provides a Covered 

Individual Attestation, as applicable 

and as further explained in the 

Technical Instructions, attesting to the 

following: 

a. Having arranged to become fully 

vaccinated against COVID–19 within 60 

days after arriving in the United States, 

or as soon thereafter as is medically 

appropriate as determined by CDC, if 

such person intends to stay in the 

United States for more than 60 days, 

unless the individual is excepted from 

this requirement. 

E. Not board any Covered Individual 

without confirming the applicable 

documentation as set forth in A, B, C, 

or D of this section. 

The attestation is attached to this 

Amended Order as Attachment A.44


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 20413 

45A parent or other authorized individual may 

present the required documentation on behalf of a 

passenger ages 2 through 17. An authorized 

individual may act on behalf of any passenger who 

is unable to act on their own behalf (e.g., by reason 

of age, or physical or mental impairment). There are 

no documentation requirements for passengers 

under the age of 2 years of age. 

46Parents or guardians of children under 2 years 

of age do not need to attest on behalf of these 

children, but they must present proof of the child’s 

age to the airline or aircraft operator before 

boarding. 

47These requirements (e.g., proof of negative 

COVID–19 test result or recovery and proof of being 

fully vaccinated against COVID–19) do not apply to 

crewmembers of airlines or other aircraft operators 

if they are traveling for the purpose of operating the 

aircraft or repositioning (i.e., on ‘‘deadhead’’ status), 

provided their assignment is under an air carrier’s 

or operator’s occupational health and safety 

program that follows applicable industry standard 

protocols for the prevention of COVID–19 as set 

forth in relevant Safety Alerts for Operators 

(SAFOs) issued by the Federal Aviation 

Administration (FAA). 

48Section 1 and Section 2 of this attestation do 

not need to be completed by or on behalf of 

children under 2 years of age. The airline or other 

aircraft operator may permit them to board an 

aircraft without an attestation. 

2. Requirements for Aircraft Passengers 

In addition, I order that any aircraft 

passenger 45 who is a Covered 

Individual under the Proclamation, 

prior to boarding an aircraft traveling 

from a foreign country to the United 

States, shall: 

A. Present to the airline or other 

aircraft operator paper or digital 

documentation reflecting Proof of Being 

Fully Vaccinated Against COVID–19 

and provide a Covered Individual 

Attestation; 

OR 

B. If not presenting Proof of Being 

Fully Vaccinated Against COVID–19, 

present to the airline or aircraft operator 

documentation confirming that they are 

an Excepted Covered Individual under 

the Proclamation and this Amended 

Order, as applicable and as further 

explained by CDC in the Technical 

Instructions. 

C. If an Excepted Covered 

Individual,46 accurately complete and 

provide the airline or aircraft operator 

with a Covered Individual Attestation, 

as further explained by CDC in the 

Technical Instructions, attesting that the 

Excepted Covered Individual (as 

applicable): 

a. Is excepted from the requirement to 

present Proof of Being Fully Vaccinated 

Against COVID–19 for one of the 

reasons set forth in the Proclamation 

and this Amended Order; 

b. has arranged to be tested with a 

COVID–19 viral test 3–5 days after 

arriving in the United States, or other 

period as specified in the most current 

CDC guidance in effect at the time the 

Excepted Covered Individual completes 

the Covered Individual Attestation, 

unless the Excepted Covered Individual 

has documentation of having recovered 

from COVID–19 in the past 90 days, or 

other period as specified in the most 

current CDC guidance in effect at the 

time the Excepted Covered Individual 

completes the Covered Individual 

Attestation; 

c. has arranged to self-quarantine, 

even if the test result to the post-arrival 

viral test is negative, unless the 

Excepted Covered Individual has 

documentation of having recovered 

from COVID–19 in the past 90 days, or 

other period as specified in the most 

current CDC guidance in effect at the 

time the Excepted Covered Individual 

completes the Covered Individual 

Attestation; and 

d. has arranged to self-isolate if the 

result of the post-arrival viral test is 

positive or if they develop COVID–19 

symptoms. 

D. If an Excepted Covered Individual, 

provide the airline or aircraft operator 

with a Covered Individual Attestation, 

as applicable and as further explained 

by CDC in the Technical Instructions, 

additionally attesting that the Excepted 

Covered Individual: 

(1) has arranged to become fully 

vaccinated against COVID–19 within 60 

days after arriving in the United States, 

or as soon thereafter as is medically 

appropriate as determined by CDC, if 

intending to stay in the United States for 

more than 60 days, unless the 

individual is excepted from this 

requirement. 

E. Retain a copy of the applicable 

documentation listed in parts A, B, C, 

and D of this section and produce such 

documentation upon request, or as 

required by, any U.S. government 

official or a cooperating state, local, 

territorial, or Tribal public health 

authority after arrival in the United 

States. 

Willfully giving false or misleading 

information to the government may 

result in criminal penalties under, inter 

alia, 18 U.S.C. 1001. 

This Amended Order shall be 

enforced through the relevant 

provisions of law, in coordination with 

other federal departments and agencies, 

including the U.S. Department of 

Justice, U.S. Department of Homeland 

Security, U.S. Department of State, and 

U.S. Department of Transportation. 

Effective Date 

This Amended Order shall enter into 

effect at 12:01 a.m. EDT on April 14, 

2022. 

ATTACHMENT A: COMBINED 

PASSENGER DISCLOSURE AND 

ATTESTATION TO THE UNITED 

STATES OF AMERICA 

This combined passenger disclosure 

and attestation fulfills the requirements 

of U.S. Centers for Disease Control and 

Prevention (CDC) Amended Orders: 

Requirements for Negative PreDeparture COVID–19 Test Result or 

Documentation of Recovery from 

COVID–19 for All Airline or Other 

Aircraft Passengers Arriving into the 

United States from Any Foreign Country 

and Implementing Presidential 

Proclamation on Advancing the Safe 

Resumption of Global Travel During the 

COVID–19 Pandemic.47 As directed by 

the CDC and the Transportation 

Security Administration (TSA), through 

Security Directive 1544–21–03 and 

Emergency Amendment 1546–21–02, 

and consistent with CDC’s Order 

implementing the Proclamation, all 

airline or other aircraft operators must 

provide the following disclosures to all 

passengers prior to their boarding a 

flight from a foreign country to the 

United States. 

Airline and Aircraft Operator Disclosure 

Requirements 

As required by United States federal 

law, all airlines or other aircraft 

operators must collect the passenger 

attestation on behalf of the U.S. 

Government.48

Required Proof of Negative COVID–19 

Test Result or Recovery From COVID– 

19 

All airlines and other aircraft 

operators must additionally confirm one 

of the following for each passenger ages 

2 years or older prior to their boarding 

a flight to the United States from a 

foreign country: 

1. A negative result for a Qualifying 

Test; or 

2. Documentation of Recovery from 

COVID–19 in the form of a positive 

COVID–19 viral test on a sample taken 

no more than 90 days prior to departure 

and a letter from a licensed healthcare 

provider or public health official stating 

that the passenger has been cleared for 

travel. 

Required Proof of COVID–19 

Vaccination for Non-U.S. Citizen, 

Nonimmigrant Air Passengers 

As directed by the TSA, including 

through a security directive or 

emergency amendment, all airlines and 

other aircraft operators must 

additionally confirm one of the 

following for each noncitizen who is a 

nonimmigrant passenger prior to their 

boarding a flight to the United States 

from a foreign country: 


khammond on DSKJM1Z7X2PROD with NOTICES
20414 Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 

49Any passenger who is not a U.S. citizen, U.S. 

national, lawful permanent resident, or an 

immigrant is referred to as a Covered Individual 

because they are covered by the Presidential 

Proclamation and CDC’s Amended Order: 

Implementing Presidential Proclamation on 

Advancing the Safe Resumption of Global Travel 

During the COVID–19 Pandemic. This term does 

not apply to crewmembers of airlines or other 

aircraft operators if such crewmembers and 

operators adhere to all industry standard protocols 

for the prevention of COVID–19, as set forth in 

relevant guidance for crewmember health issued by 

the CDC or by the FAA in coordination with the 

CDC. 

Public reporting burden of this collection of 

information is estimated to average 2 hours per 

response, including the time for reviewing 

instructions, searching existing data sources, 

gathering and maintaining the data needed, and 

completing and reviewing the collection of 

information. An agency may not conduct or 

sponsor, and a person is not required to respond to, 

a collection of information unless it displays a 

currently valid OMB Control Number. Comments 

regarding this burden estimate or any other aspect 

of this collection of information, including 

suggestions for reducing this burden, may be 

submitted to CDC/ATSDR Reports Clearance 

Officer, 1600 Clifton Road NE, MS D–74, Atlanta, 

Georgia 30333; ATTN: PRA 0920–1318. 

1. Proof of being Fully Vaccinated 

Against COVID–19; or 

2. Proof of being excepted from the 

requirement to be Fully Vaccinated 

Against COVID–19. 

OMB Control No.: 0920–1318 

Expiration Date: 05/31/2022 

PASSENGER DISCLOSURE AND 

ATTESTATION TO THE UNITED 

STATES OF AMERICA 

The information provided below must 

be accurate and complete to the best of 

the individual’s knowledge. Under 

United States federal law, the applicable 

portion of the attestation must be 

completed for each passenger ages 2 

years or older and the attestation must 

be provided to the airline or aircraft 

operator prior to boarding a flight to the 

United States from a foreign country. 

Failure to complete and present the 

applicable portion of the attestation, or 

submitting false or misleading 

information, could result in delay of 

travel, denial of boarding, or denial of 

boarding on future travel, or put the 

passenger or other individuals at risk of 

harm, including serious bodily injury or 

death. Any passenger who fails to 

comply with these requirements may be 

subject to criminal penalties. Willfully 

providing false or misleading 

information may lead to criminal fines 

and imprisonment under, among other 

provisions, 18 U.S.C. 1001. Providing 

this information can help protect you, 

your friends and family, your 

communities, and the United States. 

CDC appreciates your cooperation. 

One attestation form must be filled 

out for each passenger ages 2 years or 

older. The attestation may be filled out 

by the air passenger or on behalf of the 

air passenger by a legal representative, 

such as a parent or guardian. 

—Section 1: All air passengers ages 2 

years or older flying to the United 

States must complete Section 1. 

—Section 2: Any passenger age 2 years 

or older who is not a U.S. citizen, U.S. 

national, lawful permanent resident, 

or an immigrant (‘‘Covered 

Individual’’) who is seeking to enter 

the United States by air travel must 

also complete Section 2 of this 

attestation and comply with 

applicable after travel requirements in 

Section 2.49

I, llllllllllam attesting 

on (Select one): 

PRINT FIRST AND LAST NAME 

b My own behalf b Behalf of: 

llllllllllllllllll

PRINT FIRST AND LAST NAME 

SECTION 1: Requirement for Proof of 

Negative COVID–19 Test Result or 

Recovery From COVID–19 (check one 

box) 

A. NEGATIVE PRE-DEPARTURE TEST 

RESULT 

b I attest that I have (or the person I am 

attesting on behalf of has) received 

a negative pre-departure test result 

for COVID–19. The test was a viral 

test that was conducted on a 

specimen collected no more than 1 

calendar day before the flight’s 

departure. 

B. DOCUMENTATION OF RECOVERY 

FROM COVID–19 

b I attest that I have (or the person I am 

attesting on behalf of has) tested 

positive for COVID–19 and been 

cleared for travel by a licensed 

healthcare provider or public health 

official. The test was a viral test that 

was conducted on a specimen 

collected no more than 90 days 

before the flight’s departure. 

C. HUMANITARIAN EXEMPTION 

b I attest that I have (or the person I am 

attesting on behalf of has) received 

a humanitarian exemption to the 

testing requirement, as determined 

by CDC and documented by an 

official U.S. Government letter. 

SECTION 2: Requirement for Proof of 

COVID–19 Vaccination for Covered 

Individuals (Not a U.S. Citizen, U.S. 

National, Lawful Permanent Resident, 

or an Immigrant) 

A. FULLY VACCINATED (If you check 

box A, skip to signature page and sign 

the form to complete Attestation.) 

b I attest that I am (or the person I am 

attesting on behalf of is) fully 

vaccinated against COVID–19. 

B. NOT FULLY VACCINATED 

b I am not fully vaccinated and attest 

that I am (or the person I am 

attesting on behalf of is) excepted 

from the requirement to present 

Proof of Being Fully Vaccinated 

Against COVID–19 based on one of 

the following (check only one box, 

as applicable): 

b Diplomatic and Official Foreign 

Government Travel (complete C 

only, then sign the form to complete 

Attestation). 

b Child ages 2 through 17 years 

(complete D only, then sign the 

form to complete Attestation). 

b Participant in certain COVID–19 

vaccine trials, as determined by 

CDC (complete D only, then sign the 

form to complete Attestation). 

b Medical contraindication to an 

accepted COVID–19 vaccine, as 

determined by CDC (complete E 

only, then sign the form to complete 

Attestation). 

b Humanitarian or emergency 

exception, as determined by CDC 

and documented by an official U.S. 

Government letter (complete F only, 

then sign the form to complete 

Attestation). 

b Valid nonimmigrant visa holder 

(excluding B–1 or B–2 visas) and 

citizen of a Foreign Country with 

Limited COVID–19 Vaccine 

Availability, as determined by CDC 

(complete F only, then sign the form 

to complete Attestation). 

b Member of the U.S. Armed Forces 

or spouse or child (ages 2 through 

17 years) of a member of the U.S. 

Armed Forces (proceed to signature 

line only, then sign the form to 

complete Attestation). 

b Sea crewmember traveling 

pursuant to a C–1 and D 

nonimmigrant visa (complete F 

only, then sign the form to complete 

Attestation). 

b Person whose entry is in the U.S. 

national interest as determined by 

the Secretary of State, the Secretary 

of Transportation, the Secretary of 

Homeland Security, or their 

designees (complete G only, then 

sign the form to complete 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 20415 

Attestation). 

C. EXCEPTION: Diplomat and Official 

Foreign Government Travel 

b I attest that I am (or the person I am 

attesting on behalf of is) excepted 

from the requirement to present 

Proof of Being Fully Vaccinated 

Against COVID–19 and made the 

following arrangements (must check 

all boxes in C and then sign 

Attestation). 

b To be tested with a COVID–19 viral 

test 3–5 days after arriving in the 

United States, unless I have (or this 

person has) documentation of 

having recovered from COVID–19 

in the past 90 days; 

b To self-quarantine for a full 5 

calendar days following arrival, 

even if the result of my (or this 

person’s) post-arrival viral test is 

negative, except during periods 

when my (or this person’s) 

attendance is required to carry out 

the purposes of the diplomatic or 

official foreign government travel 

(e.g., to attend official meetings or 

events), unless I have (or this 

person has) documentation of 

having recovered from COVID–19 

in the past 90 days; and 

b To self-isolate for a full 5 calendar 

days and properly wear a wellfitting mask any time I am (or this 

person is) around others during my 

(or this person’s) isolation period 

and for an additional 5 days after 

ending isolation, 

• if the result of the post-arrival viral 

test is positive; or 

• if I develop (or this person 

develops) COVID–19 symptoms. 

D. EXCEPTIONS 

• Child ages 2 through 17 years 

• Participant in certain COVID–19 

vaccine trials as determined by CDC 

b I attest that I am (or the person I am 

attesting on behalf of is) excepted 

from the requirement to present 

Proof of Being Fully Vaccinated 

Against COVID–19 and made the 

following arrangements (must check 

all boxes in D and then sign 

Attestation). 

b To be tested with a COVID–19 viral 

test 3–5 days after arriving in the 

United States, unless I have (or the 

person has) documentation of 

having recovered from COVID–19 

in the past 90 days; 

b To self-isolate for a full 5 calendar 

days and properly wear a wellfitting mask any time I am (or this 

person is) around others during my 

(or this person’s) isolation period 

and for an additional 5 days after 

ending isolation, 

• if the result of the post-arrival viral 

test is positive, or 

• if I develop (or this person 

develops) COVID–19 symptoms. 

E. EXCEPTION: Medical 

Contraindication to an Accepted 

COVID–19 Vaccine as Determined by 

CDC 

b I attest that I am (or the person I am 

attesting on behalf of is) excepted 

from the requirement to present 

Proof of Being Fully Vaccinated 

Against COVID–19 and made the 

following arrangements (must check 

all boxes in E and then sign 

Attestation). 

b To be tested with a COVID–19 viral 

test 3–5 days after arriving in the 

United States, unless I have (or this 

person has) documentation of 

having recovered from COVID–19 

in the past 90 days; 

b To self-quarantine for a full 5 

calendar days, even if the result of 

my (or this person’s) post-arrival 

viral test is negative, unless I have 

(or this person has) documentation 

of having recovered from COVID–19 

in the past 90 days; and 

b To self-isolate for a full 5 calendar 

days and properly wear a wellfitting mask any time I am (or this 

person is) around others during my 

(or this person’s) isolation period 

and for an additional 5 days after 

ending isolation, 

• if the result of the post-arrival viral 

test is positive, or 

• if I develop (or this person 

develops) COVID–19 symptoms. 

F. EXCEPTIONS 

• Humanitarian or emergency 

exception as determined by CDC; 

• Valid nonimmigrant visa holder 

(excluding B–1 or B–2 visas) and citizen 

of a Foreign Country with Limited 

COVID–19 Vaccine Availability as 

determined by CDC; or 

• Sea crewmember traveling pursuant 

to a C–1 and D nonimmigrant visa 

b I attest that I am (or the person I am 

attesting on behalf of is) excepted 

from the requirement to present 

Proof of Being Fully Vaccinated 

Against COVID–19 and made the 

following arrangements (must check 

all boxes in F and then sign 

Attestation). 

b To be tested with a COVID–19 viral 

test 3–5 days after arriving in the 

United States, unless I have (or this 

person has) documentation of 

having recovered from COVID–19 

in the past 90 days; 

b To self-quarantine for a full 5 

calendar days, even if the result of 

my (or this person’s) post-arrival 

viral test is negative, unless I have 

(or this person has) documentation 

of having recovered from COVID–19 

in the past 90 days; 

b To self-isolate for a full 5 calendar 

days and properly wear a wellfitting mask any time I am (or this 

person is) around others during my 

(or this person’s) isolation period 

and for an additional 5 days after 

ending isolation, 

• if the result of the post-arrival viral 

test is positive; or 

• if I develop (or this person 

develops) COVID–19 symptoms; 

and 

b To become fully vaccinated against 

COVID–19 within 60 days of 

arriving in the United States, or as 

soon thereafter as is medically 

appropriate, if intending to stay in 

the United States for more than 60 

days. 

G. EXCEPTION: Person Whose Entry Is 

in the U.S. National Interest 

b I am (or the person I am attesting on 

behalf of is) excepted from the 

requirement to present Proof of 

Being Fully Vaccinated Against 

COVID–19 and made the following 

arrangements (must check all boxes 

in G and then proceed to sign 

Attestation). 

b To be tested with a COVID–19 viral 

test 3–5 days after arriving in the 

United States, unless I have (or this 

person has) documentation of 

having recovered from COVID–19 

in the past 90 days; 

b To self-quarantine for a full 5 

calendar days, even if the result of 

my (or this person’s) post-arrival 

viral test is negative, except during 

periods when my (or this person’s) 

attendance is required to carry out 

the purposes of the travel for the 

U.S. national interest (e.g., to attend 

official meetings or events), unless 

I have (or this person has) 

documentation of having recovered 

from COVID–19 in the past 90 days. 

b To self-isolate for a full 5 calendar 

days and properly wear a wellfitting mask any time I am (or this 

person is) around others during my 

(or this person’s) isolation period 

and for an additional 5 days after 

ending isolation 

• if the result of the post-arrival viral 

test is positive, or 

• if I develop (or this person 

develops) COVID–19 symptoms; 

and 

b To become fully vaccinated against 

COVID–19 within 60 days of 

arriving in the United States, or as 

soon thereafter as is medically 

appropriate, if intending to stay in 


khammond on DSKJM1Z7X2PROD with NOTICES
20416 Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 

the United States for more than 60 

days. 

llllllllllllPrint Name 

llllllllllllSignature 

lllllllDate 

Privacy Act Statement for Travelers 

Relating to the Requirement To Provide 

Proof of a Negative COVID–19 Test 

Result 

The U.S. Centers for Disease Control 

and Prevention (CDC) requires airlines 

and other aircraft operators to collect 

this information pursuant to 42 CFR 

71.20 and 71.31(b), as authorized by 42 

U.S.C. 264. Providing this information is 

mandatory for all passengers arriving by 

aircraft into the United States. Failure to 

provide this information may prevent 

you from boarding the plane. 

Additionally, passengers will be 

required to attest to providing complete 

and accurate information, and failure to 

do so may lead to other consequences, 

including criminal penalties. CDC will 

use this information to help prevent the 

introduction, transmission, and spread 

of communicable diseases by 

performing contact tracing 

investigations and notifying exposed 

individuals and public health 

authorities; and for health education, 

treatment, prophylaxis, or other 

appropriate public health interventions, 

including the implementation of travel 

restrictions. 

The Privacy Act of 1974, 5 U.S.C. 

552a, governs the collection and use of 

this information. The information 

maintained by CDC will be covered by 

CDC’s System of Records No. 09–20– 

0171, Quarantine- and Traveler-Related 

Activities, Including Records for 

Contact Tracing Investigation and 

Notification under 42 CFR parts 70 and 

71. See 72 FR 70867 (Dec. 13, 2007), as 

amended by 76 FR 4485 (Jan. 25, 2011) 

and 83 FR 6591 (Feb. 14, 2018). CDC 

will only disclose information from the 

system outside the CDC and the U.S. 

Department of Health and Human 

Services as the Privacy Act permits, 

including in accordance with the 

routine uses published for this system 

in the Federal Register, and as 

authorized by law. Such lawful 

purposes may include, but are not 

limited to, sharing identifiable 

information with state and local public 

health departments, and other 

cooperating authorities. CDC and 

cooperating authorities will retain, use, 

delete, or otherwise destroy the 

designated information in accordance 

with federal law and the System of 

Records Notice (SORN) set forth above. 

You may contact the system manager at 

dgmqpolicyoffice@cdc.gov or by mailing 

Policy Office, Division of Global 

Migration and Quarantine, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H16–4, Atlanta, 

GA 30329, if you have questions about 

CDC’s use of your data. 

Authority 

The authority for the Presidential 

Proclamation is Sections 1182(f) and 

1185(a)(1) of Title 8, and Section 301 of 

Title 3, United States Code. CDC’s Order 

is issued pursuant to the Presidential 

Proclamation. 

Sherri Berger, 

Chief of Staff, Centers for Disease Control 

and Prevention. 

[FR Doc. 2022–07450 Filed 4–4–22; 4:15 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier CMS–224–14 and 

CMS–10305] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

June 6, 2022. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number: lll, Room C4–26– 

05, 7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–224–14 Federally Qualified 

Health Center Cost Report Form 

CMS–10305 Medicare Part C and Part 

D Data Validation (42 CFR 422.516(g) 

and 423.514(j)) 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 


khammond on DSKJM1Z7X2PROD with NOTICES